Caresyntax: $180 Million (Series C Extension And Growth Debt) Raised For Advancing Precision Surgery Platform
By Amit Chowdhry ● Aug 20, 2024
Caresyntax, a vendor-neutral precision surgery platform, announced it raised a total commitment of $180 million through a series C extension and growth debt expansion round. The investors in the $180 million round include Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, Aescuvest, Optum Ventures, Cure Capital, Relyens Group, Vesalius Biocapital, Lauxera Capital, Plug & Play Growth Fund, and ProAssurance.